medigraphic.com

2009, Number 1

<< Back Next >>

Anales de Radiología México 2009; 8 (1)

Cáncer de testículo

Saavedra AJA, Ramírez CCR, Peña MGA, Stoopen RM, Barois BV, Kimura FY

Language: Spanish
References: 37
Page: 47-59
PDF size: 1003.42 Kb.


ABSTRACT

Introduction: Testicular cancer is the most common malignant neoplasia in men aged 20-35 and represents 1% of malignancies in men, although an increase in relapse has been reported in recent years. Most of testicular neoplasias are germ-sourced (95%). A non painful testicular mass is the classical show up of a primary testicular tumor, but happens in few patients. Currently, more than 95% of the testicle germ cell tumor patients can be cured.
Material and methods: More useful imaging methods in our field for testicular cancer integral evaluation are Testicular Ultrasound (UST), thorax x-ray and computed tomography (CT). However, magnetic resonance imaging (MR) and Computed tomography CT with (18F)-FDG positron emission tomography (PET-CT) and PET have a special place in different clinical situations. The method of initial imaging for timely and early detection of testicle cancer is with color Doppler ultrasound using high-frequency transducers between 7.5 to 10 MHZ.
Conclusions: A good multidisciplinary testicular tumors management has a general healing rate of about 90%, at different neoplasia stages with significant morbidity decrease.
CT is the mode of election of these neoplasms management and follow-up, while MR, PET and PET-CT, are used in case of relapses, recurrence and to assess the response to medical or surgical treatment.


REFERENCES

  1. Mayoral MA, Zenteno E, Espinosa B, Martínez S, Guevara J. Perspectiva monográfica del cáncer pulmonar: Un enfoque molecular y la metástasis al cerebro. Rev Inst Nal Enf Resp Mex; 2004; 17(4): 283-92.

  2. Tovar-Guzmán VJ, López-Antuñano FJ, Rodríguez-Salgado N. Tendencias recientes de la mortalidad por cáncer pulmonar en México, 1980-2000. Rev Panam Salud Pública 2005; 17(4): 254-62.

  3. Medina-Morales F, Salazar-Flores M. Frecuencia y patrón cambiante del cáncer pulmonar en México. Salud Pública Méx 2000; 42: 333-6.

  4. Lazcano-Ponce EC, Tovar-Guzman V, Meneses-Gonzalez F, Rascon-Pacheco RA, Hernandez-Avila M. Trends of lung cancer mortality in Mexico. Arch Med Res 1997; 28: 565-70.

  5. INEGI. Estadísticas vitales, 2007. Base de datos.

  6. Ginsberg M, Grewal R, Heelan R. Lung Cancer. Radiol Clin N Am 2007; 45: 21-43.

  7. Jimenez-Pérez RF, Granados-García M, Green-Schnneweiss L. Cáncer de pulmón. Instituto Nacional de Cancerología. Manual de Oncología. Procedimientos Médico-Quirúrgicos. México: McGraw-Hill Interamericana; 2000, p. 228-9.

  8. Travis W. Pathology of lung cancer. Clinics in chest Medicine 2002; 23: 65-6.

  9. Hansell D, Armstrong P, Lynch D, McAdams HP. Neoplasms of the lungs, airways and pleura. 4a. Ed. Imaging of diseases of the chest. Elsevier; 2005, p. 795-900.

  10. Fontana RS. The Mayo Lung Project. Presented at the International Conference on Prevention and Early Diagnosis of Lung Cancer. Varese, Italy, December 9-10, 1988.

  11. Henschke C, Yankelevitz D, Kostis W. CT screening for lung cancer. Radiol Clin N Am 2004; 42: 747-55.

  12. Bach PB, Silvestri GA, HangerM, Jett JR. Screening for Lung Cancer. Chest 2007;132; 69S-77S.

  13. Ravenel JG, Costello P, Silvestri G. Screening for Lung Cancer. AJR 2008; 190: 755-61.

  14. Chirikos T, Hazelton T, Tockman M, Clark R. Screening for Lung Cancer With CT. Chest 2002; 121; 1507-14.

  15. Teague S, Conces D. Diagnosis of Lung Cancer: Perspective of a Pulmonary Radiologist. PET Clin 2006; 1(4): 289-300.

  16. Stark P. Computed tomographic and positron emission tomographic scanning of pulmonary nodules. Up to date. AJR 2007; 188: 57-68.

  17. Winer-Muram H. The Solitary Pulmonary Nodule. Radiology 2006; 239: 34-49.

  18. Chang MP, Jin MG, Hyun JL, Chang HL, Eun JC,Jung-Gi I. Nodular Ground-Glass Opacity at Thin-SectionCT: Histologic Correlation and Evaluation of Change at Follow-up. RadioGraphics 2007; 27: 391-408.

  19. Flores-Colín I, Navarro-Reynoso F, Pérez-Romo A, Cicero-Sabido R. Lavado y cepillado bronquiales en tumores pulmonares centrales y periféricos sospechosos de malignidad. Rev Iinst Nal Enf Resp Mex 2006; 19(1): 9-15.

  20. Shreve PD, Anzai Y, Wahl R. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. RadioGraphics 1999; 19: 61-77.

  21. Gorospe L, Raman S, Echeveste J, Avril N, Herrero Y, Hernández S. Whole-body PET/CT: Spectrum of physiological variants, artifacts and interpretative pitfalls in cancer patients. Nucl Med Commun 2005; 26: 671-87.

  22. Hany TF, Steinert HC, Goerres GW, Buck A, von Schulthess GK. PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology 2002; 225: 575-81.

  23. Von Schulthess GK, Steinert HC, Hany TF. Integrated PET/CT: current applications and future directions. Radiology 2006; 238: 405-22.

  24. Silvestri G, Gould MK, Margolis ML. Noninvasive Staging of Non-small Cell Lung cancer. Chest 2007; 132; 178S-201S.

  25. Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz , Bartolucci AA. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg 2004; 78: 1017-23.

  26. Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 2005; 236: 1011-19.

  27. Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 2003; 229: 526-33.

  28. Lardinois D, Weder W, Hany T, Kamel EM, Korom S, Seifert B. Staging of nonsmall cell lung cancer with integrated positron-emission tomography. J Nucl Med 2003; 348: 2500-7.

  29. Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL. Metastases from nonsmall cell lung cancer: mediastinal staging in the 1990s-meta-analytic comparison of PET and CT. Radiology 1999; 213: 530-6.

  30. Deslauries J, Gregoire J. Clinical and surgical staging of non-small cell lung cancer. Chest 2000; 117: 96S-103S.

  31. Al-Sarraf N, Aziz R, Doddakula K, Gately K, et al. American College of Chest Physicians. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines. 2nd. Ed. Chest. 2007; 132: 202S-20S.

  32. Oriuchi N, Higuchi T, Ishikita T, Miyakubo M, Hanaoka H, Iida Y. Present role and future prospects of positron emission tomography in clinical oncology. Cancer Sci 2006; 97: 1291-7.

  33. Oriuchi N, Higuchi T, Ishikita T, Miyakubo M, Hanaoka H, et al. PET and PET/ CT of tumors of the chest. In: von Schulthess GK (ed.). Clinical molecular anatomic imaging. Philadelphia: Lippincott Williams and Wilkins; 2003, p. 291-305.

  34. Fischer BM, Mortensen J, Langer SW, Loft A, Berthelsen AK, Petersen BL. A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis. Ann Oncol 2007; 18: 338-45.

  35. Erasmus JJ, Sabloff BS. CT, Positron Emission Tomography, and MRI in Staging Lung Cancer. Clin Chest Med 2008; 29: 39-57.

  36. Wynants J, Stroobants S. Staging of Lung Cancer. PET Clin 1 2006; 1(4): 301-16.

  37. Katz Sh, Ferrara T, Alavi A, Torigian DA. PET, CT, and MR Imaging for Assessment of Thoracic Malignancy: Structure Meets Function. PET Clin 2009; 3(3): 395-410.




2020     |     www.medigraphic.com